These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada. Ng B; Sadatsafavi M; Safari A; FitzGerald JM; Johnson KM BMJ Open; 2019 Nov; 9(11):e031306. PubMed ID: 31699732 [TBL] [Abstract][Full Text] [Related]
3. Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. Aaron SD; Vandemheen KL; FitzGerald JM; Ainslie M; Gupta S; Lemière C; Field SK; McIvor RA; Hernandez P; Mayers I; Mulpuru S; Alvarez GG; Pakhale S; Mallick R; Boulet LP; JAMA; 2017 Jan; 317(3):269-279. PubMed ID: 28114551 [TBL] [Abstract][Full Text] [Related]
4. Economic impact of severe asthma in Spain: multicentre observational longitudinal study. Melero Moreno C; Quirce S; Huerta A; Uría E; Cuesta M J Asthma; 2019 Aug; 56(8):861-871. PubMed ID: 30003827 [No Abstract] [Full Text] [Related]
5. Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States. Yaghoubi M; Adibi A; Zafari Z; FitzGerald JM; Aaron SD; Johnson KM; Sadatsafavi M J Allergy Clin Immunol; 2020 May; 145(5):1367-1377.e4. PubMed ID: 31837372 [TBL] [Abstract][Full Text] [Related]
6. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. Rely K; McQuire SE; Alexandre PK; Escudero GS Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898 [TBL] [Abstract][Full Text] [Related]
7. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada. Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480 [TBL] [Abstract][Full Text] [Related]
8. Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. Bedouch P; Sadatsafavi M; Marra CA; FitzGerald JM; Lynd LD PLoS One; 2012; 7(12):e50949. PubMed ID: 23227222 [TBL] [Abstract][Full Text] [Related]
9. Direct health care costs associated with asthma in British Columbia. Sadatsafavi M; Lynd L; Marra C; Carleton B; Tan WC; Sullivan S; Fitzgerald JM Can Respir J; 2010; 17(2):74-80. PubMed ID: 20422063 [TBL] [Abstract][Full Text] [Related]
10. The morbidity and cost of vocal cord dysfunction misdiagnosed as asthma. Traister RS; Fajt ML; Petrov AA Allergy Asthma Proc; 2016; 37(2):25-31. PubMed ID: 26932166 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888 [TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Shih YC; Mauskopf J; Borker R Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma. O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of school-based asthma screening in an urban setting. Gerald JK; Grad R; Bailey WC; Gerald LB J Allergy Clin Immunol; 2010 Mar; 125(3):643-50, 650.e1-650.e12. PubMed ID: 20226298 [TBL] [Abstract][Full Text] [Related]
17. The costs of implementing the 1999 Canadian Asthma Consensus Guidelines recommendation of asthma education and spirometry for the family physician. Corrigan SP; Cecillon DL; Sin DD; Sharpe HM; Andrews EM; Cowie RL; Man SF Can Respir J; 2004; 11(5):349-53. PubMed ID: 15332137 [TBL] [Abstract][Full Text] [Related]
19. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada. Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]